Log in to save to my catalogue

Identification of TP53 mutated group using a molecular and immunohistochemical classification of end...

Identification of TP53 mutated group using a molecular and immunohistochemical classification of end...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2377345274

Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments

About this item

Full title

Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments

Publisher

England: Elsevier Inc

Journal title

International journal of gynecological cancer, 2020-05, Vol.30 (5), p.640-647

Language

English

Formats

Publication information

Publisher

England: Elsevier Inc

More information

Scope and Contents

Contents

IntroductionMolecular classification of endometrial carcinoma has been proposed to predict survival. However, its role in patient management remains to be determined. We aimed to identify whether a molecular and immunohistochemical classification of endometrial carcinoma could improve decision-making for adjuvant therapy.MethodsAll consecutive pati...

Alternative Titles

Full title

Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2377345274

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2377345274

Other Identifiers

ISSN

1048-891X

E-ISSN

1525-1438

DOI

10.1136/ijgc-2019-000871

How to access this item